Speaker



Julien Patris | Head of Patient Advocacy and Public Policy, Corporate Communication, Digital Services, EMEA, argenx

Julien Patris is Head of Patient Advocacy, Public Policy, Corporate Communication and Digital Services for EMEA at argenx and member of the EMEA Leadership Team. Prior to that, Julien had various roles in Country Management, Market Access, Commercial and External Corporate Affairs (Government, Media & Patient Relations) at International and Country level in various biopharmaceutical companies (Alnylam, Celgene). An Economist by background, Julien specialised in Health Economics & Market Access Policy and has several academic publications in the field. Julien holds a MA from the College of Europe, a MA from Sciences Po Strasbourg and a University Diploma in Market Access from Claude Bernard University of Pharmacy. Julien is guest lecturer at ESSEC since 2021.


argenx

argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases, such as generalized myasthenia gravis (gMG). Through its Immunology Innovation Program (IIP) in partnership with leading academic researchers, argenx aims to translate immunology breakthroughs into a leading portfolio of novel antibody-based medicines. argenx is evaluating treatments for multiple serious autoimmune diseases, including gMG. argenx has offices in the EU, UK, US, Japan, and Canada. For more information, visit www.argenx.com and follow us on LinkedIn and Twitter.

Powered by:
Hyphen Projects   

Let's connect:           
Book a ticket
FAQ
Contact Us
Privacy Policy
Terms & Conditions 
Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01
          
 
 

                                    

Keep me informed Download our event app


© Copyright 2023 by Hyphen Projects